Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GlycoMimetics, Inc. - Common Stock (NQ: GLYC )

0.2536 +0.0025 (+1.00%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 181,617
Open 0.2500
Bid (Size) 0.2505 (1)
Ask (Size) 0.2629 (3)
Prev. Close 0.2511
Today's Range 0.2406 - 0.2573
52wk Range 0.1406 - 3.530
Shares Outstanding 64,483,958
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting
From GlycoMimetics, Inc.
Via Business Wire
GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
-0.67%
-0.67%
1 Month
+5.71%
+5.71%
3 Month
+66.40%
+66.40%
6 Month
-19.77%
-19.77%
1 Year
-91.29%
-91.29%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why GlycoMimetics Stock is Trading Higher Monday
Via Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, CPTN, GLYC, ARC on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Profire Energy, Inc. (Nasdaq – PFIE), Cepton, Inc. (Nasdaq – CPTN), GlycoMimetics, Inc. (Nasdaq – GLYC), ARC Document Solutions, Inc. (NYSE - ARC)
From Brodsky & Smith LLC
Via GlobeNewswire
Gold Gains 1%; Phillips 66 Shares Fall After Q3 Results
Via Benzinga
GlycoMimetics Shares Are Soaring Tuesday: Here's Why
Via Benzinga
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Shareholder Alert: Ademi LLP Investigates Whether GlycoMimetics, Inc. is Obtaining a Fair Price for Its Public Shareholders
From Ademi LLP
Via Business Wire
US Stocks Mixed; McDonald's Posts Upbeat Earnings
Via Benzinga
GLYC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of GlycoMimetics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma
From GlycoMimetics, Inc.
Via Business Wire
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint
From GlycoMimetics, Inc.
Via Business Wire
GlycoMimetics Announces Strategic Review and Corporate Restructuring Plan
From GlycoMimetics, Inc.
Via Business Wire
7 Sorry Biotech Stocks Set to Make Investors Sad
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
$1M Bet On This Penny Stock? Check Out These 4 Stocks Under $2 Insiders Are Aggressively Buying
Via Benzinga
GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
From GlycoMimetics, Inc.
Via Business Wire
GlycoMimetics to Host Key Opinion Leader Event to Review Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) on June 4, 2024
From GlycoMimetics, Inc.
Via Business Wire
GLYC Stock Earnings: GlycoMimetics Misses EPS for Q1 2024
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.